← The Wire
CRBUNasdaq
Caribou Biosciences, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1619856
Develops transformative allogeneic CAR-T cell therapies for devastating diseases using novel genome-editing technology
$158M
Market cap
$1.77
Last close
+5.4%
1D
+7.9%
5D
2.8M
Volume
Price · last 39 sessions-7.3%
May 4L $1.57 · H $2.43Jun 29
125
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-K/AExecutive ChangeSep 27, 20248-K/ACompany UpdateJul 14, 20238-K/AShareholder VoteSep 23, 20228-K/AExecutive ChangeJul 18, 2022
Insider Activity
In the 90 days to Feb 25, 2026: 4 sold $47K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2026 | Kelly Timothy PChief Technology Officer | Sell | 6,228 | $1.93 | $12K |
| Feb 24, 2026 | Mcclung Barbara GChief Legal Officer | Sell | 6,938 | $1.96 | $14K |
| Feb 24, 2026 | Khan Ruhi AhmadChief Business Officer | Sell | 6,938 | $1.96 | $14K |
| Feb 24, 2026 | Kelly Timothy PChief Technology Officer | Sell | 3,147 | $1.96 | $6K |
| Feb 24, 2026 | Albertson Tina M.Chief Medical Officer | Sell | 1,066 | $1.96 | $2K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance